Stay updated on ST-400 for TDT: Safety, Tolerability, and Efficacy Clinical Trial
Sign up to get notified when there's something new on the ST-400 for TDT: Safety, Tolerability, and Efficacy Clinical Trial page.

Latest updates to the ST-400 for TDT: Safety, Tolerability, and Efficacy Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check15 days agoNo Change Detected
- Check23 days agoChange DetectedThe page has been updated to reflect the latest version of the study on ST-400 for Transfusion Dependent Beta-thalassemia, with the revision number changed from v2.14.4 to v2.15.0. Additionally, the detailed description of the study's methodology and inclusion/exclusion criteria has been removed.SummaryDifference24%
- Check30 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference2%
- Check88 days agoChange DetectedThe page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.SummaryDifference2%
- Check95 days agoChange DetectedThe website has been updated from version 2.14.1 to 2.14.2.SummaryDifference0.1%
Stay in the know with updates to ST-400 for TDT: Safety, Tolerability, and Efficacy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ST-400 for TDT: Safety, Tolerability, and Efficacy Clinical Trial page.